Ketan Patel
SlowingNamed in filings at Forest City EnterprisesOn the current fund
- Board seats filed
- 12
Named in filings at Forest City EnterprisesOn the current fund
all filings on record
last 24 months
from a verified or cited source
| Los Angeles Biosciences | Medical devices | June 2025 | None on file |
| ABK Biomedical | Medical devices | September 2022 | 270 Healthcare Growth |
| Avivomed | Medical devices | November 2021 | Hatteras Venture Partners |
| Comanche Biopharma | Biotech & pharma | June 2021 | Atlas Venture |
| Redirect Health | Healthcare services | March 2021 | None on file |
| Rallybio Holdings | Biotech & pharma | March 2020 | New Leaf |
| Menlo Therapeutics | Biotech & pharma | July 2017 | Venbio Global Strategic, Vivo Innovation, Vivo Ventures VII Affiliates |
| Amphora Medical | Medical devices | July 2017 | Baird Venture Partners |
| Avalyn Pharma | Biotech & pharma | March 2017 | Rivervest |
| NFlection Therapeutics | Biotech & pharma | December 2016 | Venbio Global Strategic, Venbio Select |
| Ivenix | Medical devices | August 2015 | None on file |
| Aclaris Therapeutics | Biotech & pharma | September 2014 | Aisling Capital, Nexeption Capital, Sofinnova Venture Partners, Vivo Innovation, Vivo Ventures VII Affiliates |
The company and date are what the SEC filing shows, not a statement of investment thesis. A partner can sit on a board for reasons that say nothing about what their firm funds today. The sector is not a filing value: it is Lev’s own classification of each company, shown only when we found a specific, checkable source for it; otherwise it reads “Not yet classified.” “Also on the board from” names another tracked firm with a partner on the same board, both with a clean identity match. It is not a claim either firm led or co-led the round, and “None on file” means no other tracked firm’s partner shares this specific board seat, not that no one else invested. Sorted newest first by default; click a column to change it. Something wrong? Tell us.
Classified sectors of companies where filings name Ketan Patel on the board, based on 12 filed seats with a verified or cited source.